Breaking News Instant updates and real-time market news.

WFC

Wells Fargo

$55.30

-0.07 (-0.13%)

10:25
06/13/18
06/13
10:25
06/13/18
10:25

Wells Fargo CFO: Consent order resolution is biggest driver for shares

Wells Fargo CFO John Shrewsberry said at the Morgan Stanley Financials Conference that the resolution of consent order is the biggest driver for shares over the next two years and that the asset cap is not a constraint on organic loan growth. Shrewsberry sees a branch sale deal on top of planned branch closures. He said that the consent order, asset cap is an opportunity for the bank to "get it exactly right." The CFO said interest income growth to drive operating leverage. Higher interest rates to compress home purchase market, he added. Commenting on customer loyalty, Shrewsberry said that levels are back up to pre-scandal levels.

  • 13

    Jun

  • 13

    Jul

  • 12

    Apr

  • 16

    Jul

  • 15

    Oct

WFC Wells Fargo
$55.30

-0.07 (-0.13%)

04/30/18
04/30/18
UPGRADE

Outperform
Wells Fargo double upgraded to Outperform at Macquarie
Macquarie analyst David Konrad upgraded Wells Fargo to Outperform from Underperform with a $61 price target citing attractive valuation, low expectations, and near-term catalysts. Konrad said valuation and consensus estimates have finally come down and said shares are trading at 11.3x his 2019 "stressed earnings" estimate, compared to super regionals trading at 12.3x. The analyst expects low expense guidance at the upcoming investor day and passing CCAR in June to serve as positive catalysts for shares.
04/17/18
BMOC
04/17/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America is the best of the 'big four' U.S. banks, says BMO Capital
BMO Capital analyst James Fotheringham kept his Market Perform rating and $34 price target on Bank of America (BAC) after its in-line Q1 earnings but raised his FY18 EPS view to $2.62 from $2.59 and FY19 view to $3.18 from $3.12. Fotheringham says than in contrast, he lowered earnings forecasts for JPMorgan (JPM), Wells Fargo (WFC), and Citigroup (C) because of higher costs and lower revenues, but Bank of America's better than expected net interest income rise justifies his view of the bank as the "best of the bunch". The analyst also notes the bank's more favorable valuation trading at a below-average two-year-forward P/E multiple despite his forecast of double the core earnings growth rate of Bank of America's peers.
04/16/18
BARD
04/16/18
NO CHANGE
Target $62
BARD
Outperform
Lower expectations limit Wells Fargo downside, says Baird
Baird analyst David George said Wells Fargo reported messy Q1 results, but lowered expectations should limit the downside in the shares. The analyst said core fees were weak, but expenses were in line as was loan growth. George maintained his Outperform rating and $62 price target on Wells Fargo shares.
04/16/18
NOMU
04/16/18
NO CHANGE
Target $68
NOMU
Buy
Wells Fargo earnings underwhelming, but not a value trap, says Nomura
Nomura Instinet analyst Bill Carcache lowered his price target for Wells Fargo to $68 from $72 saying Friday's earnings results were "underwhelming" as the company reported softer revenue growth. The analyst, however, continues to believe that shares of Wells Fargo are "not a value trap." Shareholders "able to weather the current storm" will be rewarded with 10% earnings growth, mid- to high-teens return on tangible equity, and a multiple rerating when the market regains confidence, Carcache tells investors in a research note. He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

OHI

Omega Healthcare

$31.86

0.07 (0.22%)

21:21
06/24/18
06/24
21:21
06/24/18
21:21
Downgrade
Omega Healthcare rating change at Wells Fargo »

Omega Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$86.80

0.51 (0.59%)

20:05
06/24/18
06/24
20:05
06/24/18
20:05
Hot Stocks
MiniMed 670G system real-world data show improved time in range »

Medtronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

GE

General Electric

$13.05

0.29 (2.27%)

, AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

19:31
06/24/18
06/24
19:31
06/24/18
19:31
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

GE

General Electric

$13.05

0.29 (2.27%)

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

BRK.A

Berkshire Hathaway

$286,859.95

2244.95 (0.79%)

BRK.B

Berkshire Hathaway

$188.89

0.05 (0.03%)

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

CMCSA

Comcast

$33.82

1.02 (3.11%)

CMCSK

Comcast

$0.00

(0.00%)

C

Citi

$67.20

-0.43 (-0.64%)

TWTR

Twitter

$45.90

0.68 (1.50%)

MD

Mednax

$44.99

-0.11 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 26

    Jul

  • 27

    Jul

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

OGE

OGE Energy

$34.95

0.15 (0.43%)

19:25
06/24/18
06/24
19:25
06/24/18
19:25
Downgrade
OGE Energy rating change at Goldman Sachs »

OGE Energy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Acquired by T

$0.00

(0.00%)

, CMCSA

Comcast

$33.82

1.02 (3.11%)

19:18
06/24/18
06/24
19:18
06/24/18
19:18
Hot Stocks
Box Office Battle: 'Jurassic World: Fallen Kingdom' wins weekend with $150M »

Universal (CMCSA; CMCSK)…

TWX

Acquired by T

$0.00

(0.00%)

CMCSA

Comcast

$33.82

1.02 (3.11%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$50.36

1.15 (2.34%)

FOX

21st Century Fox

$48.28

0.31 (0.65%)

FOXA

21st Century Fox

$48.59

0.25 (0.52%)

LGF.A

Lionsgate

$26.90

0.6 (2.28%)

DIS

Disney

$106.37

0.48 (0.45%)

VIAB

Viacom

$30.27

-0.13 (-0.43%)

VIA

Viacom

$35.70

0.15 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

, BRK.A

Berkshire Hathaway

$286,859.95

2244.95 (0.79%)

18:53
06/24/18
06/24
18:53
06/24/18
18:53
Periodicals
Amazon/Berkshire/JPMorgan venture takes aim at middlemen, Bloomberg says »

The health venture…

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

BRK.A

Berkshire Hathaway

$286,859.95

2244.95 (0.79%)

BRK.B

Berkshire Hathaway

$188.89

0.05 (0.03%)

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 12

    Oct

GE

General Electric

$13.05

0.29 (2.27%)

18:42
06/24/18
06/24
18:42
06/24/18
18:42
Periodicals
General Electric nearing deal to sell industrial engines unit, WSJ says »

General Electric is close…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

18:25
06/24/18
06/24
18:25
06/24/18
18:25
Conference/Events
Novo Nordisk to hold an investor and analyst event »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

ERYP

Erytech Pharma

$0.00

(0.00%)

18:17
06/24/18
06/24
18:17
06/24/18
18:17
Hot Stocks
Erytech Pharma confirms strategic focus of eryaspase on solid tumors »

Erytech Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXRX

Lexicon

$13.58

0.51 (3.90%)

18:12
06/24/18
06/24
18:12
06/24/18
18:12
Hot Stocks
Lexicon announces positive 52-week results from Sotagliflozin inTandem1 study »

Lexicon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 22

    Mar

PODD

Insulet

$97.37

0.5697 (0.59%)

18:09
06/24/18
06/24
18:09
06/24/18
18:09
Hot Stocks
Insulet presents positive results for Omnipod Horizon Hybrid Closed-Loop System »

Insulet announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

18:00
06/24/18
06/24
18:00
06/24/18
18:00
Hot Stocks
Real-World data show advantages in people treated with Eli Lilly's Trulicity »

People with type 2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

LXRX

Lexicon

$13.58

0.51 (3.90%)

17:56
06/24/18
06/24
17:56
06/24/18
17:56
Hot Stocks
Lexicon announces positive 52-week results from Sotagliflozin inTandem2 study »

Lexicon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 22

    Mar

DGX

Quest Diagnostics

$112.13

0.93 (0.84%)

17:53
06/24/18
06/24
17:53
06/24/18
17:53
Hot Stocks
Employer wellness programs may reduce risk of developing chronic conditions »

Employer wellness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

17:44
06/24/18
06/24
17:44
06/24/18
17:44
Hot Stocks
New data reinforce potential of Eli Lilly's Ultra Rapid Lispro in diabetes »

Eli Lilly's ultra…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

17:38
06/24/18
06/24
17:38
06/24/18
17:38
Hot Stocks
Eli Lilly announces findings from new analyses of EMPA-REG OUTCOME trial »

Boehringer Ingelheim and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

CTRV

ContraVir Pharmaceuticals

$1.47

-0.06 (-3.92%)

17:30
06/24/18
06/24
17:30
06/24/18
17:30
Conference/Events
ContraVir Pharmaceuticals to hold a business news update conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZFGN

Zafgen

$6.94

0.32 (4.83%)

17:27
06/24/18
06/24
17:27
06/24/18
17:27
Hot Stocks
Zafgen announces positive full results in phase 2 clinical trial of ZGN-1061 »

Zafgen announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNKD

MannKind

$1.98

0.02 (1.02%)

17:22
06/24/18
06/24
17:22
06/24/18
17:22
Hot Stocks
MannKind presents positive Afrezza clinical data from STAT, AFFINITY studies »

MannKind announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$61.46

0.295 (0.48%)

16:53
06/24/18
06/24
16:53
06/24/18
16:53
Hot Stocks
Merck presents new data from comparative trials in Type 2 diabetes »

Merck, known as MSD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 10

    Sep

  • 23

    Oct

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

04:55
06/24/18
06/24
04:55
06/24/18
04:55
Conference/Events
Novo Nordisk to hold an investor and analyst event »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

A

Agilent

$62.79

-0.24 (-0.38%)

, ABT

Abbott

$61.93

0.19 (0.31%)

04:55
06/24/18
06/24
04:55
06/24/18
04:55
Conference/Events
American Diabetes Association to hold a conference »

78th Scientific Sessions…

A

Agilent

$62.79

-0.24 (-0.38%)

ABT

Abbott

$61.93

0.19 (0.31%)

AKCA

Akcea Therapeutics

$26.24

0.4 (1.55%)

AMGN

Amgen

$184.86

-1.14 (-0.61%)

AZN

AstraZeneca

$35.06

-0.095 (-0.27%)

BAYRY

Bayer

$0.00

(0.00%)

CL

Colgate-Palmolive

$64.63

1.15 (1.81%)

DXCM

DexCom

$99.52

-0.2 (-0.20%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

IRWD

Ironwood

$19.35

0.74 (3.98%)

JNJ

Johnson & Johnson

$122.81

1.36 (1.12%)

MDT

Medtronic

$86.80

0.51 (0.59%)

MNKD

MannKind

$1.98

0.02 (1.02%)

WAKE

Wake Forest Bancshares Inc.

$0.00

(0.00%)

VLRX

Valeritas

$1.39

0.035 (2.58%)

TNDM

TNDM

SNY

Sanofi

$39.98

0.96 (2.46%)

SIEGY

Siemens

$0.00

(0.00%)

SENS

Senseonics

$4.76

-0.2 (-4.03%)

REGN

Regeneron

$331.82

2.81 (0.85%)

PODD

Insulet

$97.37

0.5697 (0.59%)

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

MRK

Merck

$61.46

0.295 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 28

    Jun

  • 02

    Jul

  • 06

    Jul

  • 12

    Jul

  • 17

    Jul

  • 18

    Jul

  • 11

    Aug

  • 27

    Aug

  • 30

    Aug

  • 10

    Sep

  • 06

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 28

    Jan

  • 22

    Mar

AMGN

Amgen

$184.86

-1.14 (-0.61%)

12:23
06/23/18
06/23
12:23
06/23/18
12:23
Hot Stocks
Amgen's Repatha 'significantly reduced' LDL-C, non-HDL-C in Type 2 diabetes »

Amgen announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

12:18
06/23/18
06/23
12:18
06/23/18
12:18
Hot Stocks
Eli Lilly's Trulicity shows promise in delivering efficacy in type 2 diabetes »

Two investigational doses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

IRWD

Ironwood

$19.35

0.74 (3.98%)

12:14
06/23/18
06/23
12:14
06/23/18
12:14
Hot Stocks
Ironwood announced Praliciguat phase IIa study data »

Ironwood Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.